Rui Avelar
2019
In 2019, Rui Avelar earned a total compensation of $1.8M as Chief Medical Officer and Head of Research and Development at Evolus, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $861,600 |
|---|---|
| Option Awards | $561,510 |
| Salary | $400,000 |
| Other | $13,500 |
| Total | $1,836,610 |
Avelar received $861.6K in non-equity incentive plan, accounting for 47% of the total pay in 2019.
Avelar also received $561.5K in option awards, $400K in salary and $13.5K in other compensation.
Rankings
In 2019, Rui Avelar's compensation ranked 6,367th out of 13,971 executives tracked by ExecPay. In other words, Avelar earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,367 out of 13,971 | 54th |
Division Manufacturing | 2,397 out of 5,701 | 58th |
Major group Chemicals And Allied Products | 873 out of 2,200 | 60th |
Industry group Drugs | 739 out of 1,886 | 61st |
Industry Pharmaceutical Preparations | 547 out of 1,398 | 61st |
Source: SEC filing on March 17, 2020.
Avelar's colleagues
We found two more compensation records of executives who worked with Rui Avelar at Evolus in 2019.